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Particular epidemic lineages (e.g. 235, 111, ST175 and 244) are associated with 
carbapenemase-producing P. aeruginosa (CPPA) isolates causing infections. Due to limited 
therapeutic options and possible carbapenemase spread, CPPA infections are of great 
concern. Nevertheless, the occurrence, genetic background and clonal dynamics over a 
long period of time of CPPA strains in Portuguese hospitals are unknown. The study aimed 
to assess the occurrence and the genetic background of CPPA isolates obtained from a 
Portuguese University Hospital. 
Carbapenem-resistant P. aeruginosa isolates obtained from different biological samples 
from inpatients attending the Hospital Geral de Santo António, Porto during 2006 (n=27) and 
2011-3 (n=135) were included. Carbapenemase production was searched by Blue-Carba. 
Carbapenemase and associated integrons were characterized by PCRs and sequencing. 
Antimicrobial susceptibility was performed by disc diffusion, E-test and agar dilution 
methods. Clonality was assessed by MLST. The bla genes location was assessed by I-CeuI/
S1 PFGE and hybridization with specific probes. Plasmid analysis included identification of 
incompatibility groups by PCR and electrotransformation of P. aeruginosa PAO1. 
Eleven isolates were Blue-Carba positive and presented blaVIM-2. These isolates were non-
susceptible to imipenem, meropenem, ceftazidime, ciprofloxacin, amikacin, tobramycin 
and gentamicin, but presented variable susceptibility to cefepime, aztreonam and 
piperacillin+tazobactam. All were susceptible to colistin. Four different integron structures 
were identified: In58, In100, In58-like, and In796 (Figure 1). Five ST’s were found: 179(n=5; 
2011-3), 175(n=2,2006), 244(n=2;2012-3), 111(n=1;2013) and 1284 (n=1;2011). In58 was the 
most widespread integron, being associated with ST’s 179, 175 and 111. blaVIM-2 gene was 
chromosomally located for nine isolates, whereas in two was plasmid located (~29 and 33 
kb plasmids). The plasmids were not associated with searched incompatibility groups.
Despite the occurrence of widespread clinically relevant clones, ST179 has been an 
important contributor to the emergence of VIM-2 producing P. aeruginosa, suggesting a 
peculiar population of this opportunistic pathogen in the studied hospital. Also, the integron 
structures carrying blaVIM-2 were similar or highly related to previously described ones in 
Pseudomonas spp. from different Portuguese settings, suggesting an interconnection 
between them and/or a great stability of genetic structures encoding this carbapenemase.
Figure 1. P. aeruginosa integrons described in this study. The arrows indicate the translation orientation of the coding 
genes. The 59 base elements are indicated by black circles.
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